SENP7

gene product
The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for many cellular processes. SUMO-specific proteases, such as SENP7, process SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]). [supplied by OMIM, Jun 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
228 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Invitrogen Antibodies
5 antibodies
antibodies-online
83 antibodies
LifeSpan BioSciences, Inc.
31 antibodies
Affinity Biosciences
1 antibody
Atlas Antibodies
1 antibody
Novus Biologicals
6 antibodies
Biorbyt
19 antibodies
Abnova Corporation
6 antibodies
Aviva Systems Biology
4 antibodies
OriGene
5 antibodies
Bioworld Technology, Inc
1 antibody
Boster Biological Technology
2 antibodies
Bethyl Laboratories
1 antibody
Acris Antibodies GmbH
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Abgent
2 antibodies
GeneTex
2 antibodies
St John's Laboratory
2 antibodies
Abiocode, Inc.
1 antibody
United States Biological
37 antibodies
MyBioSource
4 antibodies
Creative Biolabs
2 antibodies
Creative Diagnostics
2 antibodies
Sigma-Aldrich
2 antibodies
Leading Biology
2 antibodies
ProSci
2 antibodies
Everest Biotech
1 antibody